Financial Performance - The company's revenue for the year ended December 31, 2023, was RMB 292,009,000, an increase of 7.9% compared to RMB 270,536,000 for the previous year[5] - Gross profit for the same period was RMB 109,556,000, representing a gross margin of 37.5%, up from RMB 101,610,000 in the previous year[5] - The net profit for the year was RMB 7,061,000, a decrease of 41.5% from RMB 12,152,000 in the previous year[5] - The total comprehensive income for the year was RMB 8,482,000, down from RMB 12,185,000 in the previous year[5] - Basic and diluted earnings per share were RMB 0.71, compared to RMB 1.22 in the previous year, reflecting a decline of 41.8%[5] - The total comprehensive income for the year ended December 31, 2023, was RMB 8,482,000, compared to RMB 12,185,000 for the year ended December 31, 2022, representing a decrease of approximately 30%[11] - The net profit for the year ended December 31, 2023, was RMB 7,061,000, down from RMB 12,152,000 in the previous year, indicating a decline of about 42%[11] - The company reported a net income of RMB 7,650,000 for the year ended December 31, 2023, down from RMB 13,291,000 in 2022[24] - The company plans to propose a final dividend of RMB 0.38 per share for the year ended December 31, 2023, compared to RMB 0.50 per share in 2022[30] - The board of directors proposed a final dividend of RMB 0.38 per share for the current year, down from RMB 0.50 per share for the previous year[98] Assets and Liabilities - The company's total assets as of December 31, 2023, were RMB 263,682,000, slightly up from RMB 262,908,000 in the previous year[6] - Current liabilities decreased to RMB 84,881,000 from RMB 101,239,000 in the previous year, indicating improved liquidity[6] - Cash and cash equivalents increased to RMB 77,932,000 from RMB 73,011,000, showing a positive cash flow trend[6] - The company reported a decrease in trade and other payables to RMB 49,471,000 from RMB 61,615,000, reflecting better management of liabilities[7] - The total equity as of December 31, 2023, was RMB 263,682,000, up from RMB 260,200,000 as of December 31, 2022, representing a slight increase of about 1.9%[11] - The current ratio improved to 2.11 from 1.83 year-on-year, indicating better liquidity[59] - The debt-to-equity ratio decreased to approximately 32.2% from 39.9% in the previous year, reflecting a reduction in total debt[64] - Trade receivables from third parties amounted to RMB 37.228 million, up from RMB 34.949 million in the previous year[33] - The company's trade payables decreased to RMB 36.641 million from RMB 46.654 million in the previous year[36] Segment Performance - Oral care product segment revenue from external customers was RMB 101,058,000, leather care products RMB 17,864,000, and household hygiene products RMB 173,087,000, totaling RMB 292,009,000 for the year ended December 31, 2023[24] - The segment profit for oral care products was RMB 37,534,000, leather care products RMB 6,126,000, and household hygiene products RMB 65,896,000, totaling RMB 109,556,000 for the year ended December 31, 2023[24] - The household hygiene product segment's revenue increased by approximately RMB 30.5 million or 21.4% to RMB 173.1 million[44] - The oral care product segment's revenue decreased by approximately RMB 8.5 million or 7.8% to RMB 101.1 million due to necessary adjustments for compliance with labeling regulations[43] - The leather care product segment's revenue decreased by approximately RMB 0.4 million or 2.3% to RMB 17.9 million, attributed to weak demand[46] Costs and Expenses - Selling and distribution costs rose by approximately 8.6% to about RMB 49.8 million, attributed mainly to increased advertising expenses[52] - Administrative expenses increased by approximately 19.3% to about RMB 56.6 million, driven by higher personnel costs and renovations[53] - The total employee costs increased from RMB 27,044,000 in 2022 to RMB 32,778,000 in 2023[28] - Financing costs increased from RMB 245,000 in 2022 to RMB 478,000 in 2023, with bank loan interest rising from RMB 237,000 to RMB 406,000[28] - Financing costs increased by approximately 95.1% to about RMB 0.5 million, due to reduced income from financial management products and increased average loan rates[54] Research and Development - The company recognized a total of RMB 10,680,000 in research and development expenses for the year ended December 31, 2023, compared to RMB 10,781,000 in 2022[28] Market and Expansion Plans - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[5] - The company plans to further expand its household cleaning product market in Northwest and Northeast China, particularly in kitchen and bathroom cleaning products[94] - The company will launch new automotive cleaning products, including glass water, in the market[94] - The company has appointed Mr. Tong Huaizhou as the new head of retail to enhance sales in e-commerce and live broadcast businesses[94] Compliance and Governance - The company has not applied any new accounting standards that would significantly impact its financial performance for the current or prior years[15] - The company anticipates that the application of revised Hong Kong Financial Reporting Standards will not have a significant impact on its performance and financial position[19] - The board of directors confirms that the information provided in the announcement is accurate and complete, with no misleading or fraudulent elements[109] Employee Relations and Environmental Compliance - The group emphasizes the importance of maintaining good relationships with employees, with compensation policies aligned with market practices[70] - The company has implemented environmental protection measures, including noise control and waste discharge procedures, ensuring compliance with applicable environmental laws and regulations in China[83] Subsidiary Operations - Jiangsu Snow Leopard, a wholly-owned subsidiary, signed a lease agreement for a property of approximately 2,908.27 square meters in Shanghai, with a fixed rental period of two years and quarterly rent of RMB 480,000[84] Risk Management - The group does not face significant foreign exchange risk as most sales and production costs are settled in RMB, with limited expenses in USD and HKD[69] - The group has not recorded any expected credit loss for trade receivables this year, maintaining a strong collection record with no significant historical payment defaults[76] - The group has no formal foreign exchange hedging policy in place and has not engaged in any hedging activities this year to manage currency risk[75] - The group faces low credit risk from bank balances as these are held in reputable banks with high credit ratings[79] - The group does not currently have any interest rate hedging instruments in place to mitigate the risk of interest rate fluctuations[81] Audit and Reporting - The Audit Committee reviewed the company's financial performance for the three months ending March 31, 2023, and the nine months ending September 30, 2023, prior to submission to the Board[92] - The annual performance announcement will be published on the company's website and the stock exchange website[108] - The announcement will be available on the stock exchange website for at least seven days from the publication date[111]

Financial Performance - Revenue for the third quarter of 2023 reached RMB 74,857,000, an increase of 5.5% compared to RMB 71,281,000 in the same period of 2022[5] - Gross profit for the third quarter was RMB 30,439,000, representing a gross margin of 40.6%, up from RMB 26,963,000 in the previous year[5] - The net profit for the third quarter was RMB 6,297,000, a significant increase of 90.0% compared to RMB 3,309,000 in Q3 2022[5] - Basic and diluted earnings per share for the third quarter were RMB 0.63, compared to RMB 0.33 in the same quarter last year, reflecting a growth of 90.9%[5] - Total revenue for the nine months ended September 30, 2023, was RMB 203,269,000, up 9.2% from RMB 186,203,000 in the same period of 2022[5] - The company reported a total comprehensive income of RMB 5,888,000 for the nine months, compared to RMB 2,834,000 in the previous year, marking a growth of 107.5%[8] - The company reported a net profit attributable to owners of RMB 5,357,000 for the nine months ended September 30, 2023, compared to RMB 1,802,000 in the same period last year, marking an increase of 197.5%[28] - Basic earnings per share for the nine months ended September 30, 2023, was RMB 5.36, significantly higher than RMB 1.80 for the same period in 2022[28] - The net profit for the period was approximately RMB 5.4 million, a significant increase of about 197.3% from RMB 1.8 million in the previous year, resulting in a net profit margin of approximately 2.6%[36][47] Revenue Breakdown - Oral care product revenue for the nine months ended September 30, 2023, was RMB 74,318,000, down 10.4% from RMB 82,968,000 in the previous year[21] - Leather care product revenue for the nine months ended September 30, 2023, was RMB 10,689,000, a slight decrease of 3.5% from RMB 11,071,000 in the same period last year[21] - Household hygiene product revenue surged to RMB 118,262,000 for the nine months ended September 30, 2023, representing a significant increase of 28.4% from RMB 92,164,000 in 2022[21] - Revenue from household hygiene products increased by approximately RMB 26.1 million or 28.3% to RMB 118.3 million, driven by growing popularity in the domestic market[37] - Revenue from oral care products decreased by approximately RMB 8.6 million or 10.4% to RMB 74.3 million, mainly due to necessary adjustments in labeling procedures to comply with new regulations[40] Expenses and Costs - The company’s financing costs decreased to RMB 119,000 in Q3 2023 from RMB 248,000 in Q3 2022, indicating improved financial management[5] - Administrative expenses rose to approximately RMB 39.0 million, an increase of about 17.6% from RMB 33.2 million in the previous year, mainly due to higher R&D costs and employee benefits[44] - The company’s income tax expense for the nine months ended September 30, 2023, was RMB 2,161,000, compared to RMB 773,000 in the same period last year, reflecting an increase of 179.4%[23] - The depreciation of property, plant, and equipment for the nine months ended September 30, 2023, was RMB 14,069,000, up from RMB 8,035,000 in the previous year, indicating a rise of 74.5%[26] - The company reported a total inventory cost of RMB 125,388,000 for the nine months ended September 30, 2023, compared to RMB 117,806,000 in the same period last year, an increase of 6.5%[26] Dividends and Shareholder Returns - The company declared dividends of RMB 4,978,000 during the nine months, maintaining a commitment to return value to shareholders[8] - The company did not recommend the distribution of an interim dividend for the current period, compared to no interim dividend declared for the same period last year[30] - The company does not plan to declare any dividends for the period[48] Future Plans and Market Outlook - The company plans to expand its market presence and invest in new product development to drive future growth[10] - The company plans to enhance its competitive edge by increasing the application and testing standards of lysozyme technology, publishing academic papers, and applying for relevant patents[35] - The economic environment is expected to improve, but regulatory changes in China may introduce uncertainties for the promotion and sales of oral care products starting December 1, 2023[33] Corporate Governance and Compliance - The company complies with GEM listing rules and corporate governance codes, striving to maintain the highest standards[67] - Since its listing, the company has maintained sufficient public float to comply with GEM listing rules[69] - The audit committee has reviewed the unaudited consolidated results for the period and found them to comply with applicable accounting standards and legal requirements[65] - The company has not purchased, sold, or redeemed any listed securities during the period[60] - The controlling shareholder has not violated any terms of the non-competition agreement as of the report date[63] Shareholding Structure - 中寶瑪儷持有中國金典集團57.56%的股份，童星控股持有10.69%的股份[55] - 於2023年9月30日，董事會確認無其他人士擁有需披露的股份或權益[57] - 於本報告日期，執行董事包括李秋雁、童星及杜永衛，獨立非執行董事包括葉敬仲、潘慶偉及鄧維祐[71] - 公司於2016年採納的購股權計劃有效期為10年，至2026年結束[58]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全 部或任何部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8281） 二 零 二 三 年 第 三 季 度 業 績 公 告 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在主 板上市的公司帶有較高投資風險。有意投資的人士應了解投資於該等公司的 潛在風險，並應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買 賣之證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高 流通量的市場。 本公告乃根據GEM證券上市規則（「GEM上市規則」）之規定提供有關中國金典集 團有限公司（「本公司」，連同其附屬公司，「本集團」）之資料。本公司各董事（「董 事」）共同及個別對本公告承擔全部責任。 ...

Financial Performance - Revenue for the six months ended June 30, 2023, was RMB 128,412 thousand, an increase of 11.3% compared to RMB 114,922 thousand for the same period in 2022[10]. - Gross profit for the same period was RMB 47,442 thousand, representing a gross margin of 36.9%, up from RMB 41,434 thousand in 2022[10]. - The company reported a loss before tax of RMB 170 thousand for the six months ended June 30, 2023, compared to a loss of RMB 1,574 thousand in the previous year, indicating an improvement[10]. - For the six months ended June 30, 2023, the total comprehensive income was a loss of RMB 709,000, compared to a loss of RMB 666,000 for the same period in 2022[19]. - The company reported a net loss attributable to owners of RMB 940 thousand for the six months ended June 30, 2023, compared to a loss of RMB 1,507 thousand for the same period in 2022[41]. - The basic and diluted loss per share for the six months ended June 30, 2023, was RMB 0.09, compared to a loss of RMB 0.15 for the same period in 2022[10]. - The company’s net loss for the period was approximately RMB 0.9 million, a reduction of about 37.6% from a net loss of RMB 1.5 million in the same period last year[68][82]. Assets and Liabilities - Total assets as of June 30, 2023, were RMB 329,908 thousand, down from RMB 364,147 thousand as of December 31, 2022[12]. - Current liabilities decreased to RMB 73,180 thousand from RMB 101,239 thousand at the end of 2022, reflecting improved liquidity[12]. - Total liabilities decreased to RMB 75,395 thousand as of June 30, 2023, from RMB 103,947 thousand as of December 31, 2022[36]. - The company reported a decrease in retained earnings to RMB 126,579,000 as of June 30, 2023, down from RMB 132,497,000 at the beginning of the year[19]. - Trade receivables decreased to RMB 29,495,000 as of June 30, 2023, from RMB 34,726,000 as of December 31, 2022, representing a decline of approximately 15%[51]. - Trade payables decreased to RMB 37,530,000 as of June 30, 2023, down from RMB 46,654,000 as of December 31, 2022, indicating a reduction of about 19%[60]. - Contract liabilities decreased to RMB 10,392,000 as of June 30, 2023, from RMB 20,883,000 at the end of the previous year, reflecting a decline of approximately 50%[60]. Cash Flow and Management - Cash and cash equivalents decreased to RMB 39,297 thousand from RMB 73,011 thousand, indicating a need for cash management strategies[12]. - The net cash used in operating activities for the six months ended June 30, 2023, was RMB 28,171,000, slightly higher than RMB 26,358,000 in the previous year[22]. - The company’s investment activities resulted in a net cash outflow of RMB 4,192,000 for the period, contrasting with a net inflow of RMB 1,928,000 in the previous year[22]. - The company’s financing activities led to a net cash outflow of RMB 1,698,000, compared to RMB 13,716,000 in the same period last year[22]. - The company has capital commitments of RMB 1,958,000 for the acquisition of property and equipment as of June 30, 2023[64]. - The group maintained bank borrowings of RMB 15.0 million as of June 30, 2023, unchanged from December 31, 2022, with a cash and bank balance of approximately RMB 39.3 million, down from RMB 73.0 million[87]. Revenue Segments - The company’s revenue segments include oral care, leather care, and household hygiene products, with all revenues recognized at a point in time upon delivery[28]. - Oral care segment revenue decreased by 8.1% to RMB 48,546 thousand from RMB 52,744 thousand year-on-year[32]. - Household hygiene segment revenue increased significantly by 30.7% to RMB 73,360 thousand from RMB 56,097 thousand year-on-year[32]. - Revenue from household hygiene products increased by approximately RMB 17.3 million or 30.8% to about RMB 73.4 million, while oral care product sales decreased by approximately RMB 4.2 million or 8.0% to RMB 48.5 million due to necessary adjustments in labeling procedures[68][75]. Future Plans and Strategies - The company plans to focus on market expansion and new product development in the upcoming quarters[18]. - The company plans to expand into the Middle East and Central Asia markets next year as part of its strategy to enhance product competitiveness[72]. - A dedicated team will be established to manage the filing requirements for toothpaste products in compliance with new regulations effective December 1, 2023, to mitigate uncertainties in promotion and sales[72]. Corporate Governance - The audit committee has reviewed the unaudited condensed consolidated results for the period and confirmed compliance with applicable accounting standards and GEM listing rules[112]. - The company has complied with the corporate governance code as per GEM listing rules throughout the reporting period[115]. - The board of directors has confirmed adherence to the established code of conduct for securities trading during the reporting period[109]. - The company has established an audit committee consisting of three independent non-executive directors to oversee financial reporting and risk management[112]. Shareholder Information - Major shareholders included Zhongbao Mali Investment Limited with a 57.56% stake and Tongxing Holdings Limited with a 10.69% stake as of June 30, 2023[102]. - The company declared a final dividend of HKD 0.559 per share for the year ended December 31, 2022, totaling HKD 5,590,000[45]. - The company does not recommend the payment of an interim dividend for this period[83].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全 部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8281） 截 至 二 零 二 三 年 六 月 三 十 日 止 六 個 月 之 中 期 業 績 公 告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小 型公司提供一個上市的市場。有意投資的人士應了解投資於該等公司的潛在 風險，並應經過審慎周詳的考慮後方作出投資決定。 由於在GEM上市的公司普遍為中小型公司，在GEM買賣的證券可能會較於聯 交所主板買賣的證券承受較大的市場波動風險，同時無法保證在GEM買賣的 證券會有高流通量的市場。 本公告乃根據GEM證券上市規則（「GEM上市規則」）之規定提供有關中國金典集 團有限公司（「本公司」，連同其附屬公司統稱「本集團」）之資料。本公司各董事 ...

Financial Performance - The company reported a revenue of RMB 66,018,000 for the first quarter of 2023, an increase of 10.8% compared to RMB 59,724,000 in the same period last year[4]. - Gross profit for the first quarter of 2023 was RMB 24,343,000, up 17.5% from RMB 20,764,000 year-on-year[4]. - The company achieved a net profit of RMB 1,031,000 in Q1 2023, a significant improvement from a net loss of RMB 4,072,000 in Q1 2022[4]. - Basic and diluted earnings per share for the first quarter of 2023 were RMB 0.09, compared to a loss per share of RMB 0.41 in the previous year[4]. - For the three months ended March 31, 2023, the total revenue was approximately RMB 66.0 million, an increase of about 10.5% compared to RMB 59.7 million for the same period last year[27]. - The net profit for the same period was approximately RMB 1.0 million, a turnaround from a net loss of approximately RMB 4.1 million in the previous year, representing a difference of about RMB 5.1 million[27]. - The overall gross profit margin increased from approximately 34.8% in the previous year to about 36.9% in the current period[27]. - The group recorded total revenue of approximately RMB 66.0 million, an increase of approximately RMB 6.3 million or 10.5% compared to RMB 59.7 million in the same period last year[34]. - Gross profit increased to approximately RMB 24.3 million, an increase of approximately RMB 3.5 million or 17.2% from approximately RMB 20.8 million in the same period last year[38]. - Net profit for the period was approximately RMB 1.0 million, a turnaround from a net loss of approximately RMB 4.1 million in the same period last year, resulting in a net profit margin of approximately 1.6%[44]. Revenue Segmentation - Revenue from the household hygiene products segment increased to approximately RMB 38.5 million, up approximately RMB 10.2 million or 36.1% from approximately RMB 28.3 million in the same period last year[34]. - Revenue from the oral care products segment decreased to approximately RMB 23.5 million, down approximately RMB 4.0 million or 14.6% from approximately RMB 27.5 million in the same period last year[34]. Cost Management - Selling and distribution costs decreased to approximately RMB 12.3 million, down approximately RMB 0.4 million or 3.5% from approximately RMB 12.8 million in the same period last year[39]. - Administrative expenses increased to approximately RMB 13.5 million, an increase of approximately RMB 0.7 million or 5.1% from approximately RMB 12.8 million in the same period last year[40]. - Interest expenses decreased to approximately RMB 131,000, down approximately RMB 117,000 or 47.2% from approximately RMB 248,000 in the same period last year[41]. - The financing costs decreased to RMB 131,000 in Q1 2023 from RMB 248,000 in Q1 2022, indicating improved financial management[4]. Tax and Other Income - The company incurred a tax credit of RMB 1,548,000 in Q1 2023, compared to RMB 403,000 in the same period last year, showing a positive trend in tax management[4]. - The income tax expense for the current period included current tax of RMB 1,567 thousand and deferred tax of RMB (19) thousand, totaling RMB 1,548 thousand[18]. - The company reported other income of RMB 1,116,000 in Q1 2023, compared to RMB 648,000 in the same period last year, reflecting a growth of 72.2%[4]. Corporate Governance and Compliance - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited consolidated performance for the period and confirmed compliance with applicable accounting standards and GEM listing rules[65]. - The company maintains sufficient public float as required by GEM listing rules from the listing date to the report date[67]. - The company has complied with the corporate governance code as per GEM listing rules during the reporting period[66]. - The company has confirmed that all directors have complied with the trading code during the reporting period[59]. Future Outlook and Strategic Initiatives - The company plans to establish a dedicated team for toothpaste filing management in response to regulatory changes[30]. - The company aims to enhance its product competitiveness by improving production capacity and technical leadership, especially in oral care products[32]. - The company anticipates opportunities and challenges in the second quarter of 2023 due to the gradual reduction of pandemic impacts on the Chinese economy[29]. - The company expects that changes in Chinese regulations regarding cosmetic labeling and toothpaste management will introduce uncertainties in the promotion and sales of oral care products[29]. Dividend Policy - The company did not recommend any dividend payment for the current period, consistent with the previous year[26]. - The board has resolved not to declare any dividends for the period, consistent with the previous year[45]. Shareholder and Securities Information - The company has confirmed that no directors or controlling shareholders have any interests in competing businesses during the reporting period[61]. - The company has not granted any rights to directors or their immediate family members to benefit from purchasing the company's shares or debt securities during the reporting period[56]. - No purchases, sales, or redemptions of the company's listed securities have occurred during the reporting period[57]. - The company has published its quarterly performance announcement and report, which can be accessed on the Hong Kong Stock Exchange website and the company's website[69].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全 部或任何部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8281） 二 零 二 三 年 第 一 季 度 業 績 公 告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小 型公司提供一個上市的市場。有意投資的人士應瞭解投資於該等公司的潛在 風險，並應經過審慎周詳的考慮後方作出投資決定。 由於在GEM上市的公司普遍為中小型公司，在GEM買賣的證券可能會較於主 板買賣的證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會 有高流通量的市場。 本公告乃根據聯交所GEM證券上市規則（「GEM上市規則」）之規定提供有關中國 金典集團有限公司（「本公司」及連同其附屬公司（「本集團」））之資料。本公司各 董事（「董事」）共同及個別對本公告承擔全部 ...

Financial Performance - The group's revenue for the fiscal year ended December 31, 2022, was approximately RMB 270.5 million, a decrease of about 8.5% from approximately RMB 295.7 million in the previous year[11]. - The gross profit margin decreased from approximately 39.1% to about 37.6%, reflecting increased promotional efforts to maintain market share[11]. - The net profit for the year was approximately RMB 12.2 million, a decrease of about 5.4% compared to the previous year, with a net profit margin of approximately 4.5%, up from 4.3%[11]. - Revenue from household hygiene products for the year was approximately RMB 142.6 million, down from RMB 151.5 million in the previous year[13]. - Revenue from oral care products decreased by approximately RMB 12.6 million or 10.3% to RMB 109.6 million, primarily due to reduced foot traffic in physical retail stores in China and weak demand on online platforms[24]. - Revenue from household hygiene products decreased by approximately RMB 8.9 million or 5.9% to RMB 142.6 million, mainly impacted by COVID-19[24]. - Gross profit decreased by approximately 12.2% to about RMB 101.6 million, with a gross profit margin of approximately 37.6%, down from 39.1% in the previous year[28][29]. - Selling and distribution costs decreased by approximately RMB 13.0 million or 22.1% to RMB 45.9 million, attributed to reduced promotional expenses and temporary sales personnel costs[30]. - Administrative expenses slightly increased by approximately RMB 1.1 million or 2.4% to RMB 47.4 million, driven by increased business entertainment and management salaries[31]. Dividend and Shareholder Information - The board proposed a final dividend of RMB 0.005 per share, compared to no dividend in the previous year[17]. - The total amount of the proposed final dividend is approximately RMB 5,000,000[92]. - The company has adopted a dividend policy in accordance with the GEM Listing Rules, which will consider financial performance, cash flow, and overall business conditions before declaring dividends[91]. - The company will suspend the registration of shareholders from May 31 to June 1, 2023, for the purpose of determining eligibility for the final dividend[96]. - As of December 31, 2022, the company's distributable reserves amounted to approximately RMB 121.7 million, which includes share premium and other reserves after deducting accumulated losses[124]. Operational Challenges and Future Outlook - The company faced significant operational challenges due to COVID-19, impacting supply chains and workforce availability throughout the year[11]. - The company expects a stable recovery in the Chinese economy in 2023, despite ongoing global economic challenges[18]. - The management team remains committed to expanding operations in the oral care and household hygiene sectors to create shareholder value[18]. - The group has implemented measures to mitigate supply chain risks, including increasing inventory levels and enhancing online sales performance[54]. - A new kitchen and bathroom cleaning product is set to be launched, anticipated to become a new growth point for the company[18]. Governance and Management - The board of directors is responsible for independent oversight of the group's management, ensuring compliance with governance standards[87]. - The group has maintained a consistent approach to corporate governance, ensuring transparency and accountability in its operations[91]. - The company has established a remuneration committee to review the remuneration policies and structures for directors and senior management[152]. - The board consists of three executive directors and three independent non-executive directors, ensuring a balanced governance structure[174]. - The company has established specific committees, including the Audit Committee, Remuneration Committee, and Nomination Committee, to enhance governance effectiveness[184]. - The governance policies and practices are regularly reviewed to ensure compliance with legal and regulatory requirements[185]. Risk Management and Compliance - The group faced no significant foreign exchange risk as most sales and production costs are settled in RMB, with limited expenses in USD and HKD[48]. - The group has no formal foreign exchange hedging policy and has not engaged in hedging activities during the year[55]. - The group has implemented internal guidelines for risk management and financial performance review, ensuring strategic oversight[177]. - The Audit Committee confirmed that the annual report complies with GEM listing rules[189]. Employee and Community Engagement - The total employee cost for the year was approximately RMB 27.0 million, a decrease from RMB 27.3 million in 2021, primarily due to reduced sales and marketing[49]. - The group had a total of 266 employees as of December 31, 2022, a slight decrease from 268 employees in 2021[152]. - The group made charitable donations totaling RMB 325,000 during the year, down from RMB 430,000 in the previous year[157]. Financial Position and Equity - The company's total equity as of December 31, 2022, was approximately RMB 260.2 million, an increase from RMB 248.0 million in the previous year[37]. - The debt-to-equity ratio as of December 31, 2022, was approximately 5.8%, a decrease from 6.0% in the previous year, due to an increase in total equity[43]. - The company had outstanding bank loans of approximately RMB 15.0 million as of December 31, 2022, unchanged from the previous year[38]. - As of December 31, 2022, the group had approximately RMB 70.4 million in financial liabilities due within the next 12 months, with net current assets of approximately RMB 83.7 million[58]. Share Option Scheme - The company adopted a share option scheme on June 17, 2016, aimed at attracting and retaining top personnel and providing additional incentives to employees and partners[137]. - The maximum number of shares involved in the share option plan shall not exceed 10% of the total issued shares as of the company's listing date, which amounts to 100,000,000 shares[140]. - Each participant's allocation limit under any share option plan shall not exceed 1% of the issued shares within any 12-month period[141]. - The share option plan will be valid for ten years from the adoption date, with approximately three years remaining as of the report date[149]. - The share option plan does not have performance targets that must be met before exercising any options[145].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全 部或任何部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8281） 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 之 年 度 業 績 公 告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小 型公司提供一個上市的市場。有意投資的人士應瞭解投資於該等公司的潛在 風險，並應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市的公司普遍為中小型公司，在GEM買賣的證券可能會較於聯交 所主板買賣的證券承受較大的市場波動風險，同時無法保證在GEM買賣的證 券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內 容而產生或因倚 ...

Financial Performance - Revenue for the third quarter of 2022 was RMB 71,281,000, a decrease of 6.3% compared to RMB 76,418,000 in the same period of 2021[7] - Gross profit for the third quarter of 2022 was RMB 26,963,000, down 7.7% from RMB 29,217,000 in the third quarter of 2021[7] - The net profit for the third quarter of 2022 was RMB 3,309,000, a decrease of 20.1% compared to RMB 4,143,000 in the same period of 2021[7] - Basic and diluted earnings per share for the third quarter of 2022 were RMB 0.33, down from RMB 0.41 in the third quarter of 2021[7] - Total comprehensive income for the third quarter of 2022 was RMB 3,500,000, compared to RMB 4,283,000 in the same period of 2021, reflecting a decrease of 18.2%[7] - The total revenue for the nine months ended September 30, 2022, was RMB 186,203,000, a decrease of 9.2% from RMB 204,861,000 in the same period of 2021[7] - The gross profit for the nine months ended September 30, 2022, was RMB 68,397,000, down 14.4% from RMB 79,904,000 in the same period of 2021[7] - The company reported a net profit of RMB 1,802,000 for the nine months ended September 30, 2022, compared to RMB 3,361,000 in the same period of 2021, representing a decline of 46.5%[7] - Total revenue for the nine months ended September 30, 2022, was RMB 186,203 thousand, a decrease of 9.1% compared to RMB 204,861 thousand for the same period in 2021[28][31] - Net profit attributable to owners for the nine months ended September 30, 2022, was RMB 1,802 thousand, a decline of 46.4% from RMB 3,361 thousand in the same period of 2021[41][45] - Basic earnings per share for the nine months ended September 30, 2022, was RMB 0.0018, compared to RMB 0.0034 for the same period in 2021[42][45] - The net profit for the period was approximately RMB 1.8 million, down about 46.4% from RMB 3.4 million in the previous year, resulting in a net profit margin of 1.0%, down from 1.6%[55][65] - The overall gross profit margin decreased to approximately 36.7%, down 2.3 percentage points from 39.0% in the previous year[58] Revenue Breakdown - Oral care products generated revenue of RMB 82,968 thousand, down 6.4% from RMB 88,776 thousand in the previous year[28][31] - Household hygiene products revenue was RMB 92,164 thousand, a decrease of 10.3% from RMB 102,714 thousand in the same period last year[28][31] - Leather care products revenue fell to RMB 11,071 thousand, down 17.1% from RMB 13,371 thousand year-over-year[28][31] - Revenue from oral care products decreased by approximately 6.5% to RMB 83.0 million, while revenue from household hygiene products decreased by 17.2% to RMB 92.2 million, primarily due to weak demand from distributors affected by the pandemic[56] Expenses and Costs - The company’s financing costs for the third quarter of 2022 were RMB 248,000, an increase from RMB 166,000 in the same period of 2021[7] - Sales and distribution costs decreased by approximately RMB 8.4 million or 19.4% to RMB 35.0 million, mainly due to a reduction in temporary sales personnel costs[61] - Administrative expenses slightly decreased by approximately RMB 0.5 million or 1.5% to RMB 33.2 million, attributed to lower maintenance and consultancy costs compared to the previous year[62] - Interest expenses for the period were approximately RMB 0.5 million, a decrease of about 7.7% from RMB 0.6 million in the previous year, mainly due to a reduction in loan amounts[63][64] Dividends and Shareholder Information - The company did not recommend any dividend for the nine months ended September 30, 2022, consistent with the previous year[46] - The company does not recommend the distribution of any dividends for the period[66] - Major shareholder Zhongbao Mali holds 575,625,000 shares, representing 57.56% of the company's equity[75] - Tongxing Holdings owns 106,875,000 shares, accounting for 10.69% of the company's equity[75] - The company has not granted any stock options under its stock option plan since its adoption in June 2016[80] Future Plans and Strategies - The company plans to continue focusing on the development of oral care, leather care, and household hygiene products to drive future growth[21] - The company plans to strengthen its epidemic prevention measures and optimize its supply chain system to prepare sufficient goods for distributors in lockdown areas[51] - The company aims to invest more resources to enhance connections with companies looking to develop the bio-oral care product market[51] Compliance and Audit - The audit committee has reviewed the unaudited consolidated results for the period and confirmed compliance with applicable accounting standards[88] - The company has maintained sufficient public float as required by GEM listing rules since its listing date[93] Depreciation and Tax - The company reported a total tax expense of RMB 1,828 thousand for the nine months ended September 30, 2022[38] - The depreciation of property, plant, and equipment for the nine months was RMB 8,035 thousand, down from RMB 9,566 thousand in the previous year[41][45] Product Development - The company has not identified any new products or technologies in the current report, focusing instead on existing product lines[25][26]